Open Accessibility Menu
Hide

Stroke Quality & Outcomes

After having been a certified Advanced Primary Stroke Center since 2011, Redlands Community Hospital was certified by The Joint Commission as an Advanced Thrombectomy Capable Stroke Center in 2020.

RCH expanded its neuroscience program services to include advanced and complex neurosurgical and neuroendovascular therapies for both Ischemic (blocked) and Hemorrhagic (bleed) types of stroke and other neurological disease conditions.

The completion of the 1100 square foot Hybrid Neurointerventional/ Neurosurgical Operating Room Suite, the first of its kind in the Inland Empire, the ongoing ESRI Emergency Room expansion and remodeling with a dedicated Stroke Treatment Room and CT scanner, and the latest certification by The Joint Commission, is a testament to the organization’s commitment to providing quality care in the region.

Redlands Community Hospital offers diagnostic cerebral angiography and other neuroendovascular/ neurosurgical treatment procedures (glossary below) such as:

  • Endovascular coiling and surgical clipping for brain aneurysms
  • Carotid stenting
  • Intracranial angioplasty and embolization
  • Carotid endarterectomy
  • Lumbar drain placement

2025 AIS Cases Provided Thrombolysis Treatment & Expired < 72 hrs. after Treatment

In 2025, thirty-six stroke cases received thrombolytic treatment one case expired while in the hospital < 72 hrs. post thrombolysis.

2025 Thrombolysis Treatment & Discharge Location

In 2025, 61% of patients who received thrombolytic therapy were discharged home. The remaining patients required continued care and were discharged to rehabilitation facilities, SNF, or LTC.

A notable decline began in Qtr. 3 and continued into Qtr. 4. In response, the multidisciplinary team has intensified efforts to support patients and reduce the need for SNF placement through collaboration with Case Management and caregivers to facilitate continued therapy at home.


2025 Median Door to Needle (drug)

Throughout 2025, stroke alert volume remained relatively stable, while door-to-needle times progressively decreased, demonstrating sustained quarter-over-quarter improvement.

Our pre-activated stroke alert time was –2 minutes for 2025.

The volume of patients meeting thrombolytic eligibility criteria increased over time.

Overall door-to-needle was 42 minutes. Placing RCH below the recommended 45 minutes door to needle time frame.


2025 sICH Cases who received TNK &/or MER Treatment

Of the 36 patients who received thrombolytic therapy, 13% developed a symptomatic intracerebral hemorrhage. Of the 23 patients who underwent thrombectomy, 0.8% developed a symptomatic intracerebral hemorrhage.

Notably, of the hemorrhagic cases, three occurred in patients who received thrombolytic therapy only, while the remaining two occurred in patients who received both thrombolytic therapy and thrombectomy.

With state-of-the-art equipment and neuroendovascular physician expertise, the RCH stroke program now provides 24/7 treatment for eligible stroke patients for mechanical endovascular reperfusion therapy or thrombectomy, which is a procedure to remove blood clots causing blockage to critical parts of the brain, and restore blood flow to allow the highest chance of recovery for the patient. The RCH team works hard to improve blood flow to blocked areas of the brain as much as possible, and achieving that technical goal is even more rewarding when the stroke patient starts manifesting the resolution of their deficits.

Recognition and Achievement

Since 2014, Redlands Community Hospital’s Stroke Program has been recognized by the American Heart Association/ American Stroke Association’s Get With The Guidelines-Stroke for quality achievement in stroke care and timeliness in providing stroke treatment to eligible patients.

  • 2025 GOLD Plus Target: Stroke Honor Roll Elite, Type 2 Diabetes Honor Roll
  • 2024 GOLD Plus Target: Stroke Honor Roll Elite, Type 2 Diabetes Honor Roll
  • 2023 Gold Plus Target: Stroke Honor Roll Elite
  • 2022 Gold Plus Target: Stroke Honor Roll Elite, Type 2 Diabetes Honor Roll
  • 2021 Gold Plus Target: Stroke Honor Roll, Target: Type 2 Diabetes Honor Roll
  • 2020 Gold Plus Target: Type 2 Diabetes Honor Roll
  • 2019 Gold Plus Target: Stroke Honor Roll Elite

For more information on our Stroke Program and services, please call (909)335-5501 or email StrokeProgram@redlandshospital.org

Definitions

Carotid endarterectomy: a surgical procedure used to reduce the risk of stroke by correcting stenosis (narrowing) of the common artery or internal carotid artery.

Carotid stenting: a procedure that opens clogged arteries to restore blood flow to the brain. They are often performed to treat or prevent stroke.

Cerebral angiography: a diagnostic technique that uses an X-ray imaging guidance and a special dye, known as contrast, to determine the health of blood vessels in the brain and evaluate blow flow.

Endovascular coiling: a procedure performed to block blood flow into an aneurysm (a weakened area in the wall of an artery).

Mechanical endovascular reperfusion therapy or thrombectomy: emergent treatment for stroke that removes larger clots that block large blood vessels in the brain.

Intracranial angioplasty and embolization: used to widen blood vessels in the brain and treat abnormal blood vessels in the brain.

Lumbar drain placement: a procedure to place a small tube in your lower back and into the spinal column to drain or collect cerebral spinal fluid.